Health Professions Subcommittee
	AMENDED REPORT
	October, 2007
I.	SCHOOL OF PHARMACY

A.	Add a New Program	Eff. Term:	Spring 2008
		Certificate:   Preclinical Drug Development (12)
12 unit certificate which typically will consist of RSCI 530, RSCI 531, RSCI 532 and an additional, director-approved course.
•	Approved

B.	Add four new courses			Eff. Term:	Spring 2008
		1.   RSCI-530	Translational Medicine: An Overview (2)
An overview of principles and concepts underlying drug discovery and development, including terminology of translational science.  Recommended Preparation: Undergraduate degree in pharmacy, medical or independent health sciences, engineering or equivalent mix of post secondary training and industry experience; enrollment in MS Regulatory Science, Certificate in Preclinical Drug Development.
>	Approved

	2.  RSCI-531	Drug Discovery (4)
Examines the process of drug discovery from selection of disease and therapeutic target to characterization and validation of lead drug candidates.  Recommended Preparation: Undergraduate degree in pharmacy, medical or independent health sciences, engineering or equivalent mix of post-secondary training and industry experience; enrollment in MS Regulatory Science, Certificate in Preclinical Drug Development.
>	Approved

	3.  RSCI-532	Early Stage Drug Development (3)
Explores the activities involved in transforming an early drug or biological candidate to a drug approved for marketing by regulatory authorities. Recommended Preparation: Undergraduate degree in pharmacy, medical or independent health sciences, engineering or equivalent mix of post-secondary training and industry experience; enrollment in MS Regulatory Science, Certificate in Preclinical Drug Development.
>	Approved

			4.  RSCI-601  Biomedical Commerce (4)
Introduction to business principles appropriate to medical products, including: supply and demand, product entry-exit strategies, financing, reimbursement, marketing and pricing in global marketplace. Recommended Preparation: Undergraduate degree in pharmacy, medical or independent health sciences, engineering or equivalent mix of post-secondary training and industry experience; enrollment in MS Regulatory Science.
>	Approved
Course was originally submitted with the title 'Biomedical Business,' but after discussion with the Marshall School of Business, the School of Pharmacy agreed to change the title to 'Biomedical Commerce.'